Surgery for a post-chemotherapy residual mass in seminoma

Journal of Urology

Volumn 157, Issue 3, 1997, Pages 860-862

  Herr, Harry W ^a   Sheinfeld, Joel ^a   Puc, Heide S ^a   Heelan, Robert ^a   Bajorin, Dean F ^a   Mencel, Peter ^a   Bosl, George J ^a   Motzer, Robert J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

seminoma; testicular neoplasms; testis

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEMINOMA; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR VOLUME;

EID: 0031023802     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65065-1     Document Type: Article

References (15)

1. Mencel, P. J., Motzer, R. J., Mazumdar, M., Vlamis, V., Bajorin, D. F. and Boses, G. J.: Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients. J. Clin. Oncol., 12: 120, 1994.
2. Loehrer, P. J., Sr., Birch, R., Williams, S. D., Greco, F. A. and Einhorn, L. H.: Chemotherapy of metastatic seminoma: the Southeastern Cancer Study Group experience. J. Clin. Oncol., 5: 1212, 1987.
3. Motzer, R., Bosl, G., Heelan, R., Fair, W., Whitmore, W., Sogani, P., Herr, H. and Morse, M.: Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy. J. Clin. Oncol., 5: 1064, 1987.
4. Fosså, S. D., Kullman, G., Lien, H. H., Stenwig, A. E. and Ous, S.: Chemotherapy of advanced seminoma: clinical significance of radiological findings before and after treatment. Brit. J. Urol., 64: 530, 1989.
5. Peckham, M. J., Horwich, A. and Hendry, W. F.: Advanced seminoma: treatment with cis-platinum-based combination chemotherapy or carboplatin. Brit. J. Cancer, 52: 7, 1985.
6. Fossa, S. D., Borge, L., Aass, N., Johannessen, N. B., Stenwig, A. E. and Kaalhus, O.: The treatment of advanced metastatic seminoma: experience in 55 cases. J. Clin. Oncol., 5: 1071, 1987.
7. Friedman, E. L., Garnick, M. B., Stomper, P. C., Mauch, P. M., Harrington, D. P. and Richie, J. P.: Therapeutic guidelines and results in advanced seminoma. J. Clin. Oncol., 3: 1325, 1985.
8. Puc, H. S., Heelan, R., Mazumdar, M., Herr, H., Scheinfeld, J., Vlamis, V., Bajorin, D. F., Bose, G. J., Mencel, P. and Motzer, R. J.: Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center. J. Clin. Oncol., 14: 454, 1996.
9. Herr, H. W. and Bosl, G. J.: Residual mass after chemotherapy for seminoma: changing concepts of management. J. Urol., 137: 1234, 1987.
10. Stomper, P. C., Jochelson, M. S., Friedman, E. L., Garnick, M. B. and Richie, J. P.: CT evaluation of advanced seminoma treated with chemotherapy. AJR, 146: 745, 1986.
11. Motzer, R. J., Mazumdar, M., Bosl, G. J., Bajorin, D. F., Amsterdam, A. and Vlamis, V.: High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity. J. Clin. Oncol., 14: 1098, 1996.
12. Schmoll, H. J., Harstrick, A., Bokemeyer, C., Diekmann, K. P., Clemm, C., Berdel, W. E., Souchan, R., Schöber, C., Wilke, H. and Poliwoda, H.: Single-agent carboplatin for advanced seminoma. A phase II study. Cancer, 72: 237, 1993.
13. Schultz, S. M., Einhorn, L. H., Conces, D. J., Jr., Williams, S. D. and Loehrer, P. J.: Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience. J. Clin. Oncol., 7: 1497, 1989.
14. Horwich, A., Dearnaley, D. P., Duchesne, G. M., Williams, M., Brada, M. and Peckham, M. J.: Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. J. Clin. Oncol., 7: 1150, 1989.
15. Srougi, M., Simon, S. D. and Menezes de Goes, G.: Vinblastine, actinomycin D, bleomycin, cyclophosphamide, and cis-platinum for advanced germ cell testis tumors: Brazilian experience. J. Urol., 134: 65, 1985.